Outcomes following tacrolimus systemic immunosuppression for penetrating keratoplasty in infants and young children.

We compare our results to published literature: 1-year graft survival was higher than previously reported, with lower failure due to rejection. Overall infection rates did not increase, however, proportionally, severe infections were higher. Overall graft survival is at least comparable to reported literature.